Unknown

Dataset Information

Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.


ABSTRACT:

Background

Over the past few years, next-generation sequencing (NGS) has become reliable and cost-effective, and its use in clinical practice has become a reality. A relevant role for NGS is the prediction of response to anti-EGFR agents in metastatic colorectal cancer (mCRC), where multiple exons from KRAS, NRAS, and BRAF must be sequenced simultaneously.

Methods

We optimized a 14-amplicon NGS panel to assess, in a consecutive cohort of 219 patients affected by mCRC, the presence and clinico-pathological associations of mutations in the KRAS, NRAS, BRAF, and PIK3CA genes from formalin-fixed, paraffin-embedded specimens collected for diagnostics and research at the time of diagnosis.

Results

We observed a statistically significant association of RAS mutations with sex

SUBMITTER: Isnaldi E 

PROVIDER: S-EPMC6489172 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature